1.
Pakulska AO, Rządzińska N, Błoch AM, Fimiarz KJ, Kłosowicz AK, Miller MA, et al. DIFFERENCES IN SAFETY PROFILE AND ADVERSE EFFECTS OF ORAL AND SUBCUTANEOUS GLP-1 ANALOGUES: A SYSTEMATIC REVIEW AND REAL-WORLD DATA ANALYSIS (2024–2026). IJITSS [Internet]. 2026 Jun. 29 [cited 2026 Sep. 12];5(2(50). Available from: https://rspublisher.org/index.php/ijitss/article/view/5685